Laureen Debuono
CIK 1034447 · Chief Financial Officer · last filed 2024-12-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RANI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RANI | Director | — | $0.64 | — | $0 | 5 | 2024-12-17 |
| PLSE | Director | — | $44.43 | — | $0 | 1 | 2021-10-06 |
| Turtle Beach Corp (HEAR) Delisted | Director | 6,258 | $17.47 | $109.3K | $0 | 4 | 2017-02-10 |
| PAMT | Director | 3,198 | $11.59 | $37.1K | $0 | 1 | 2014-02-03 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | Director | — | — | — | $0 | 1 | 2013-08-15 |
Recent Filings · Page 2 of 2
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-03-21 | — | Disp (D) | — | $0 | |
| 2014-02-03 | PAMT | Grant (A) | +3,198 | $0 | EDGAR |
| 2013-08-15 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-02-11 | — | Tax (F) | −1,650 | -$12.5K | |
| 2007-08-31 | — | Sell (S) | −2,175 | -$17.2K | |
| 2007-08-06 | — | Mixed | — | -$5.5K | |
| 2007-07-11 | — | Mixed | — | -$158.0K | |
| 2007-03-20 | — | Grant (A) | — | $0 | |
| 2007-02-09 | — | Grant (A) | +4,614 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.